Prolactinoma and pregnancy - a series of cases including pituitary apoplexy.J Obstet Gynaecol. 2017 Apr; 37(3):284-287.JO
Abstract
The objective of this article is to evaluate the impact of pregnancy in women with prolactinoma, the possible consequences of therapy maintenance/discontinuation during pregnancy and to assess the type of delivery and maternal-foetal obstetrical outcome. A retrospective study of all pregnant women with prolactinoma in our Centre between 2006 and 2014 was made. We had 35 cases of pregnant women with prolactinoma, two of which had an episode of pituitary apoplexy during the second trimester. At the time of conception, most women were being treated with 5 mg bromocriptine. The majority of women had suspended medication in the 8th week of gestation. Caesarean rate was 48.6%. The maternal foetal outcome was favourable in all cases.
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
27866462
Citation
Galvão, Ana, et al. "Prolactinoma and Pregnancy - a Series of Cases Including Pituitary Apoplexy." Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology, vol. 37, no. 3, 2017, pp. 284-287.
Galvão A, Gonçalves D, Moreira M, et al. Prolactinoma and pregnancy - a series of cases including pituitary apoplexy. J Obstet Gynaecol. 2017;37(3):284-287.
Galvão, A., Gonçalves, D., Moreira, M., Inocêncio, G., Silva, C., & Braga, J. (2017). Prolactinoma and pregnancy - a series of cases including pituitary apoplexy. Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology, 37(3), 284-287. https://doi.org/10.1080/01443615.2016.1233946
Galvão A, et al. Prolactinoma and Pregnancy - a Series of Cases Including Pituitary Apoplexy. J Obstet Gynaecol. 2017;37(3):284-287. PubMed PMID: 27866462.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Prolactinoma and pregnancy - a series of cases including pituitary apoplexy.
AU - Galvão,Ana,
AU - Gonçalves,Daniela,
AU - Moreira,Marta,
AU - Inocêncio,Gonçalo,
AU - Silva,Clara,
AU - Braga,Jorge,
Y1 - 2016/11/21/
PY - 2016/11/22/pubmed
PY - 2017/10/17/medline
PY - 2016/11/22/entrez
KW - Prolactinoma
KW - caesarean section
KW - maternal outcome
KW - perinatal outcome
KW - pituitary apoplexy
KW - pregnancy
SP - 284
EP - 287
JF - Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
JO - J Obstet Gynaecol
VL - 37
IS - 3
N2 - The objective of this article is to evaluate the impact of pregnancy in women with prolactinoma, the possible consequences of therapy maintenance/discontinuation during pregnancy and to assess the type of delivery and maternal-foetal obstetrical outcome. A retrospective study of all pregnant women with prolactinoma in our Centre between 2006 and 2014 was made. We had 35 cases of pregnant women with prolactinoma, two of which had an episode of pituitary apoplexy during the second trimester. At the time of conception, most women were being treated with 5 mg bromocriptine. The majority of women had suspended medication in the 8th week of gestation. Caesarean rate was 48.6%. The maternal foetal outcome was favourable in all cases.
SN - 1364-6893
UR - https://www.unboundmedicine.com/medline/citation/27866462/Prolactinoma_and_pregnancy___a_series_of_cases_including_pituitary_apoplexy_
DB - PRIME
DP - Unbound Medicine
ER -
